Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

KETamine Sedation As Neuroprotective Agent Following Out-of-hospital Cardiac Arrest (OHCA) - the KETOHCA Trial

NCT06744361 is registered in ClinicalTrials.gov with Christian Hassager as lead sponsor.

NCT NCT06744361
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06744361 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
KETamine Sedation As Neuroprotective Agent Following Out-of-hospital Cardiac Arrest (OHCA) - the KETOHCA Trial
Lead sponsor
Christian Hassager
Phase
Phase 2
Overall status
Recruiting
Start date
December 12, 2024
Completion date
September 1, 2027
Enrollment
282 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

out-of-hospital cardiac arrest (ohca)